{"id":"W4400014677","doi":"10.1111/cea.14527","title":"The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation","year":2024,"lang":"en","type":"article","venue":"Clinical & Experimental Allergy","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital; McGill University; University of Toronto; Montreal Children's Hospital","funders":"KalVista Pharmaceuticals; Genentech; LEO Pharma; Eli Lilly and Company; Ono Pharmaceutical; Celltrion; Eisai; Intellia Therapeutics; Grifols; GlaxoSmithKline; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Ipsen; Glenmark Pharmaceuticals; Mitsubishi Tanabe Pharma Corporation; BioCryst; Ionis Pharmaceuticals; Celldex Therapeutics; AstraZeneca; CSL Behring; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Sanofi; Takeda Pharmaceutical Company; Amgen; Pfizer","keywords":"Medicine; Angioedema; Health care; Specialty; Disease registry; Observational study; Disease; Family medicine; Pathology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005532345,0.0001944484,0.0002782014,0.00004132288,0.0002859049,0.0001365606,0.0001057737,0.0001258314,0.0005102237],"category_scores_gemma":[0.00008002068,0.000139488,0.0002676669,0.0001388056,0.000310506,0.00013307,0.0001088559,0.0001768393,0.00004453473],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001389031,"about_ca_system_score_gemma":0.0002367953,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000503783,"about_ca_topic_score_gemma":0.00005465414,"domain_scores_codex":[0.9981561,0.0001581348,0.0006894958,0.0004775313,0.0002445524,0.0002741583],"domain_scores_gemma":[0.9986548,0.0006963891,0.00009214264,0.0003069679,0.00005547726,0.0001941888],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004436083,0.0003178219,0.005581675,0.0001799505,0.001027061,0.00008238807,0.003122537,0.000005362278,0.02275727,0.05967369,0.04016277,0.8666459],"study_design_scores_gemma":[0.002597046,0.001312386,0.04353508,0.0001857915,0.0001108845,0.0001212799,0.00560409,0.00187301,0.03913686,0.001167595,0.9039922,0.0003637662],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5445895,0.4328518,0.001673453,0.009101423,0.003511176,0.001483996,0.00002471958,0.0004407803,0.006323188],"genre_scores_gemma":[0.9862909,0.003406211,0.003843539,0.0008567167,0.001680961,0.0001356693,0.0002008559,0.00004880172,0.003536312],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8662821,"threshold_uncertainty_score":0.5688157,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04211469504800174,"score_gpt":0.4773435709421989,"score_spread":0.4352288758941971,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}